RESULT OF TEST-2 OF OCF-2011 | TOP 3 WINNERS ANNOUNCED
That was real traffic of candidates on GPAT-TUTOR Platform for OCF 2011's test-2. The no. of candidates participating in OCF competition is increased for TEST-2. The test was much easier than test -1 and passing percentage was 50 % ... But Let me tell you very few of you cross that margin. But don’t worry as in GPAT if you would score atleast 35-40 %, you can qualify the pharma giant entrance.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.
Cadila Pharmaceuticals Ltd. (CPL) Is one of India’s most reputed, research-based, techno-savvy pharmaceutical companies with a focus in the area of Formulations & APIs and having its Corporate Office at Bhat, Ahmedabad and State-of-art manufacturing facilities at Dholka, Ankleshwar, Kadi and Jammu accredited with USFDA, MHRA, TGA, MCA, MCC & WHO certifications.


